Fundraising Fox

Achieve Life Sciences

NASDAQ: ACHV

Vancouver, B.C., US · Delaware corporation · 3 known investors

Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation. It is pursuing FDA approval for the drug as a new option for people trying to quit smoking or vaping in the US.

BiotechHealthtech

Founders & leadership

AC
Anthony ClarkeCo-founder
RS
Richard StewartCo-founder
CJ
Cindy JacobsExecutive
JX
Jaime XinosExecutive
JB
John BencichExecutive

Board

BM
Bridget MartellBoard director
MM
Martin MattinglyBoard director
VH
Vaughn HimesBoard director
DJ
Donald JosephBoard director
JM
Jay MoyesBoard director

Investors · 3

venBio PartnersSan Francisco
Vivo CapitalPalo Alto · $10M – $50M
Frazier Life SciencesreportedPalo Alto

Reported raises · per SEC filings

Form D private placements

$18.9M disclosed across 1 round · 2022

▶$18.9MraisedDec 2022 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cindy JacobsExecutive Officer, Director
  • Anthony ClarkeExecutive Officer
  • Bridget MartellDirector
  • Martin MattinglyDirector
  • Jaime XinosExecutive Officer
  • Vaughn HimesDirector
  • Donald JosephDirector
  • John BencichExecutive Officer, Director
  • Richard StewartDirector
  • Jay MoyesDirector
Offering amount
$25M
Amount sold
$18.9M
Finders' fees
$756K
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Seeking Alpha31 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies competing with Achieve Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$320K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financingstocktitan.net · Aug 2026Achieve Life Sciences Announces Up to $354 Million Private Placementfinance.yahoo.com · Apr 2026Achieve Life Sciences Raises Capital, Appoints New CEO - TipRanks.comtipranks.com · Apr 2026

Frequently asked questions

What does Achieve Life Sciences do?
Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation. It is pursuing FDA approval for the drug as a new option for people trying to quit smoking or vaping in the US.
Who founded Achieve Life Sciences?
Achieve Life Sciences was founded by Anthony Clarke, Richard Stewart.
Who are Achieve Life Sciences's investors?
Achieve Life Sciences's investors include venBio Partners, Vivo Capital, Frazier Life Sciences.
How much funding has Achieve Life Sciences raised?
Achieve Life Sciences has disclosed $18.9M raised across 1 round.
Where is Achieve Life Sciences headquartered?
Achieve Life Sciences is headquartered in Vancouver, B.C., US.